Japan News
-
OxOnc, Pfizer drug trial to be held in Asia
Japan | News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2013
Singapore: OxOnc Development, an oncology development company founded by pharmaceutical development executives and oncol...Read more
-
Invivoscribe, Astellas sign agreement for companion diagnostics
Japan | News | By BioSpectrum Bureau | 0 Comment | 29 Apr, 2015
Invivoscribe Technologies Inc., a US-based company with international experience in commercializing in-vitro diagnostic ...Read more
-
Japan Pharma Manufacturers Association partners with Medidata
Japan | News | By BioSpectrum Bureau | 0 Comment | 01 Sep, 2015
Singapore: Medidata, a provider of cloud-based solutions for clinical research, has collaborated with Japan Pharmaceutic...Read more
-
Takeda partners with WIPO to accelerate R&D
Japan | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2016
Singapore: Japan based Takeda Pharmaceutical has participated in WIPO Re:Search, a consortium to accelerate research and...Read more
-
CPhI Japan set to begin tomorrow
Japan | News | By BioSpectrum Bureau | 0 Comment | 21 Apr, 2015
Singapore: CPhI Japan, organized by UBM EMEA, is set to begin at the Big Sight Exhibition Center, Tokyo, Japan, from Apr...Read more
-
Astella, Potenza partner to enhance immune-oncology programs
Japan | News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2015
Singapore: Japan's Astellas Pharma and Potenza Therapeutics, a biotechnology company developing a portfolio of immuno-on...Read more
-
Tosoh buys an Indian invitro diagnostics company
Japan | News | By BioSpectrum Bureau | 0 Comment | 21 Apr, 2015
Singapore: As part of expanding and strengthening its bioscience operations, Japan-based Tosoh Corporation has acquired ...Read more
-
Naviscan gets Japan approval for PET
Japan | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2012
Singapore: Naviscan, the global leader in organ-specific molecular imaging, received Shonin approval from the Japanese M...Read more
-
Daiichi Sankyo Korea, Daewoong Pharma to co-promote oral anti-coagulant in Korea
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Dec, 2015
Tokyo: Japanese pharmaceutical giant, Daiichi Sankyo Company Limited has announced that its wholly-owned subsidiary in ...Read more
-
Chugai-Athersys collaborate to develop MultiStem Cell Therapy
Japan | News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2015
Singapore: Chugai Pharmaceutical and US-based Athersys have entered into a partnership and license agreement to exclusiv...Read more
-
Sanford Consortium, Takeda Pharmaceutical partner in $10-million innovation alliance
Japan | News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2015
The Sanford Consortium for Regenerative Medicine in La Jolla, California, and the Japanese major Takeda Pharmaceutical C...Read more
-
Roche to develop companion diagnostic test for Acute Coronary Syndrome
Japan | News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2015
Roche has announced that the company has entered into an agreement to develop a companion diagnostic (CDx) test for dalc...Read more
-
Japan's Carna Biosciences collaborates with Johnson & Johnson Innovation
Japan | News | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2015
Carna Biosciences has signed a worldwide licensing agreement with Janssen Biotech Inc., one of the Janssen Pharmaceutica...Read more
-
Transcatheter heart devices to see surge in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 31 May, 2013
Singapore: Millennium Research Group (MRG) estimates that transcatheter aortic valve replacement (TAVR) devices will be ...Read more
-
Daiichi Sankyo initiates Hokusai-VTE cancer study
Japan | News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2015
Daiichi Sankyo Company Limited has initiated its Hokusai-VTE Cancer, a multinational study which will investigate the ef...Read more
-
Mesoblast files for approval of stem cell product in Japan
Japan | News | By BioSpectrum Bureau | 0 Comment | 07 Sep, 2015
Tokyo: Australia's regenerative medicine company, Mesoblast Limited has announced that its allogeneic mesenchymal stem c...Read more
-
Syros to replicate Japanese clinical trials of cancer drug in US and Europe
Japan | News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2015
Tokyo: Cambridge-based Syros Pharmaceuticals has entered into an exclusive license agreement with the Japanese oncology...Read more
-
Cellmid to supply diagnostic antibodies to Fujikura
Japan | News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2013
Singapore: Cellmid has signed an important option agreement with listed Japanese company Fujikura Kasei, a major suppli...Read more
